These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8442163)

  • 1. Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients.
    Tollemar J; Ringdén O; Andersson S; Sundberg B; Ljungman P; Sparrelid E; Tydén G
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1495-7. PubMed ID: 8442163
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.
    Tollemar J; Ringdén O; Andersson S; Sundberg B; Ljungman P; Tydén G
    Bone Marrow Transplant; 1993 Dec; 12(6):577-82. PubMed ID: 8136741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial.
    Tollemar J; Höckerstedt K; Ericzon BG; Jalanko H; Ringdén O
    Transplant Proc; 1995 Feb; 27(1):1195-8. PubMed ID: 7878847
    [No Abstract]   [Full Text] [Related]  

  • 5. Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies.
    Tollemar J; Höckerstedt K; Ericzon BG; Sundberg B; Ringdén O
    Transplant Proc; 1994 Jun; 26(3):1833. PubMed ID: 8030161
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of liposomal amphotericin B in bone marrow transplant.
    Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H
    J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of nephrotoxicity of high-cumulative dose of liposomal amphotericin B in a pediatric patient who underwent allogeneic bone marrow transplantation.
    Cesaro S; Zignol M; Burlina AB; Tridello G; Visintin G; Messina C
    Pediatr Transplant; 2006 Mar; 10(2):255-8. PubMed ID: 16573618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.
    Kelsey SM; Goldman JM; McCann S; Newland AC; Scarffe JH; Oppenheim BA; Mufti GJ
    Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
    Ringdén O; Andström EE; Remberger M; Dahllöf G; Svahn BM; Tollemar J
    Pediatr Transplant; 1997 Nov; 1(2):124-9. PubMed ID: 10084772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin.
    Ringdén O; Andström E; Remberger M; Svahn BM; Tollemar J
    Bone Marrow Transplant; 1994; 14 Suppl 5():S10-4. PubMed ID: 7703925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome).
    Boletis JN; Pefanis A; Stathakis C; Helioti H; Kostakis A; Giamarellou H
    Clin Infect Dis; 1999 Jun; 28(6):1308-9. PubMed ID: 10451172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
    Shah T; Lai WK; Gow P; Leeming J; Mutimer D
    Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High cure rate of invasive fungal infections in immunocompromised children using ambisome.
    Ringdén O; Tollemar J; Dahllöf G; Tydén G
    Transplant Proc; 1994 Feb; 26(1):175-7. PubMed ID: 8108927
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia.
    Salonen JH
    Acta Biomed; 2006; 77 Suppl 2():28-31. PubMed ID: 16918065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal amphotericin (AmBisome) is safe in bone marrow transplantation for primary immunodeficiency.
    Pasic S; Flannagan L; Cant AJ
    Bone Marrow Transplant; 1997 Jun; 19(12):1229-32. PubMed ID: 9208117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients.
    Berkowitz RJ; Hughes C; Rudnick M; Gordon EM; Strandjord S; Cheung NK; Warkentin P; Coccia PF
    Am J Pediatr Hematol Oncol; 1985; 7(1):82-6. PubMed ID: 3898901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of liposomal amphotericin B for the prophylaxis of fungal infection in solid organ transplant recipients].
    López-Medrano F; Díaz-Pedroche C; Lumbreras C; Aguado JM
    Rev Esp Quimioter; 2005 Mar; 18(1):14-20. PubMed ID: 15915227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients.
    Tollemar J; Andersson S; Ringdén O; Tydén G
    Mycoses; 1992; 35(9-10):215-20. PubMed ID: 1291871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.